Synthetic opioid production in Europe with Paul Griffiths
Addiction Audio4 Huhti 2024

Synthetic opioid production in Europe with Paul Griffiths

In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss organised crime and its impact on cocaine production, drug availability and the potential for drug contamination. They also cover fentanyl and the potential for a heroin drought resulting from changes in opium production in Afghanistan.


Paul talks about the complexities of European drug markets explaining how they commonly respond to changes in both supply and demand. Elle and Paul then discuss how researchers can monitor drug trends through wastewater analysis and other methods.


“These are often very small labs, but because of the potency of these drugs, it means very small production runs can have quite a big impact on local drug consumption patterns and mortality and morbidity. So we saw a few years ago, ten or fifteen years, one lab in central Europe we had a very brief outbreak of deaths in about three countries all related to a very very small, a kitchen lab it was actually in someone’s kitchen but it had an impact.”


Paul Griffiths is the scientific director for the EMCDDA – the European Monitoring Centre for Drugs and Drug Addiction


Original article: Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future by Paul Griffiths and colleagues. Published in Addiction (2024)


The opinions expressed in this post reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(116)

JITAIs and using smartphones to prevent lapse with Olga Perskie

JITAIs and using smartphones to prevent lapse with Olga Perskie

Rob Calder talks to Dr Olga Perski about her recent research on just-in-time adaptive interventions (JITAIs) whereby smartphones are used to help prevent lapses among people who are trying to quit or ...

27 Loka 202130min

Mental imagery and cocaine craving with John Marsden

Mental imagery and cocaine craving with John Marsden

Rob Calder talks to Professor John Marsden about cocaine cravings. Professor Marsden discusses the lack of pharmacological treatments for cocaine, and about his recent study using mental imagery to ad...

20 Loka 202131min

Drug treatment commissioning and market mechanisms with Alison Ritter

Drug treatment commissioning and market mechanisms with Alison Ritter

Professor Alison Ritter talks about her recent paper “Are market mechanisms associated with alcohol and other drug treatment outcomes” and about the Australian context of drug treatment provision and ...

15 Loka 202122min

The Paper Authoring Tool (PAT) with Robert West

The Paper Authoring Tool (PAT) with Robert West

Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, abou...

14 Syys 202127min

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about...

15 Heinä 202116min

Cannabis, schizophrenia and genetics with Emma Johnson

Cannabis, schizophrenia and genetics with Emma Johnson

Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this resear...

14 Kesä 202116min

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Rob Calder talks to Dr Thomas Mason about his research on pay for performance models of addiction treatment and how they were associated with increased emergency hospital admissions. Mason T, Whittake...

1 Kesä 202119min

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Rob Calder talks to Dr Máirtín McDermott and Dr Leonie Brose about their research into the effectiveness of e-cigarettes for quitting smoking.McDermott M.S, East K.A, Brose L.S, McNeill A, Hitchman S....

28 Huhti 202117min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-poliisin-mieli
docemilia
rss-duodecim-lehti
utelias-mieli
rss-astetta-parempi-elama-podcast
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
filocast-filosofian-perusteet
rss-ammamafia
rss-tiedetta-vai-tarinaa
rss-lapsuuden-rakentajat-podcast
rss-sosiopodi